Business Success Story: From Rags to Pharma Riches, Dilip Shanghvi's Inspiring Journey to Billionaire Success
When he started his pharma company in 1983 with 5 products and 5 people, hardly anyone could guess the success he will achieve. In 1987 when the company began selling on a national scale, it was ranked 108th. Now it ranks 6th, which is nothing short of mind-blowing.
Dec 19, 2023, 12:28 PM IST
Sun Pharma Q3 profit zooms nearly 4-fold to Rs 1,241.85 crore
The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal hit by one-time deferred tax adjustment.
Feb 13, 2019, 10:12 AM IST
Sun Pharma writes to SEBI over whistleblower complaint, says certain entities doing unfair biz practices against it
In November 2018, a whistleblower approached Sebi with a document alleging various irregularities by the company, its promoter and others.
Jan 18, 2019, 17:22 PM IST
Sun Pharma Q1 net profit at Rs 982.51 crore
Sun Pharmaceutical Industries on Tuesday reported a consolidated net profit of Rs 982.51 crore for the quarter ended June 30, 2018.
Aug 14, 2018, 15:24 PM IST
Sun Pharma to increase stake in Ranbaxy Malaysia to 79.5%
The share purchase will be for a cash consideration of MYR 2,861,365.65, Sun Pharma said.
Oct 13, 2017, 00:01 AM IST
Sun Pharma sees single-digit decline in revenues for FY18
On US FDA inspection, Shanghvi said on completion of re- inspection, the USFDA issued nine observations for the Halol facility and the company is currently in the process of implementing the requisite remediation steps.
Sep 03, 2017, 14:00 PM IST
Cadila Healthcare soars 7% on USFDA nod for hypertension drug
The scrip settled 7.02 per cent higher at Rs 494.95 on the BSE. In the intra-day trade, the stock climbed 8.95 per cent to the day's high of Rs 503.90 on the BSE.
Aug 24, 2017, 17:14 PM IST
Sun Pharma drops over 5%; shares hit 52-week low
The stock plunged 5.13 percent to settle at Rs 474.75 on BSE. During the day, it slumped 5.63 percent to Rs 472.20 -- its 52-week low.
Aug 09, 2017, 19:04 PM IST
US FDA accepts application for psoriasis drug: Sun Pharma
Drug major Sun Pharmaceutical Industries on Wednesday said the US health regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis.
May 24, 2017, 11:49 AM IST
USFDA issues 11 observations for Sun Pharma's Dadra facility
Drug major Sun Pharmaceutical Industries has received 11 observations from the US health regulator after inspection of its Dadra facility.
Apr 22, 2017, 18:54 PM IST
Sensex down; Tata Motors, Sun Pharma drag
As a result of disappointed December-quarter earnings by major players, Indian shares fell on Wednesday, with Tata Motors and Sun Pharmaceutical Industries weighing on the indexes.
Feb 15, 2017, 12:07 PM IST
Sun Pharma subsidiary invests 14.6% stake in US company for $13 million
Pharamceutical major Sun Pharma's subsidiary has invested USD 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc, announced the company on Friday.
Dec 23, 2016, 12:37 PM IST
Sun Pharma acquires Ocular Technologies Sarl
Pharmaceutical major Sun Pharma has informed BSE that it has completed the acquisition of the US-based eye care specialist Ocular Technologies Sarl.
Dec 16, 2016, 12:05 PM IST
India's Sun Pharma joins hands with ICGEB to develop dengue vaccine
The vaccine will be targeted against all the four serotypes of dengue virus that cause fever, headache, muscle and joint pain, rash in humans.
Oct 19, 2016, 14:39 PM IST
Sun Pharma in $50 million deal with Spanish firm
Indian drug major Sun Pharmaceutical Industries Ltd said it entered into $50 million licensing agreement with Spanish firm Almirall for the development and commercialisation of tildrakizumab for psoriasis in Europe.
Jul 28, 2016, 11:35 AM IST
Sun Pharma launches sunscreen brand Suncros
New Delhi: Drug major Sun Pharmaceutical Industries on Wednesday announced the launch of its sunscreen brand 'Suncros' through the company's Global Consumer Healthcare business vertical.
Jun 08, 2016, 15:57 PM IST
Sun Pharma gets USFDA nod for eye inflammation drug
The company is likely to commercialise BromSite through its newly formed US-based division Sun Ophthalmics in the second half of 2016.
Apr 11, 2016, 08:23 AM IST
Sun Pharma makes tender offer to acquire InSite Vision
Drug major Sun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash.
Sep 29, 2015, 19:41 PM IST
Sun Pharma seals deal to acquire US-based InSite Vision
Drug major Sun Pharmaceutical Industries has entered into an agreement with InSite Vision to acquire the US-based eyecare firm for around USD 48 million plus related debt and other transaction costs to strengthen its branded ophthalmic portfolio in the US.
Sep 16, 2015, 11:21 AM IST
Sun Pharma completes acquisition of GSK Australia opiates biz
The company has started the integration of opiates business after completion of the deal, which would strengthen its position in global market and expand its narcotics raw material (NRM) market share.
Sep 01, 2015, 13:01 PM IST
